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Cellular/Molecular
Motoneurons Secrete Angiogenin to Induce RNA Cleavage
in Astroglia
Alexandra Skorupa,1,2* Matthew A. King,1* Isabela M. Aparicio,1Heiko Dussmann,1 Karen Coughlan,1 Bridget Breen,1
Dairin Kieran,1 Caoimhin G. Concannon,1 Philippe Marin,2 and Jochen H. M. Prehn1
1Department of Physiology and Medical Physics, Centre for the Study of Neurological Disorders, Royal College of Surgeons in Ireland, Dublin 2, Ireland, and
2De´partement de Neurobiologie, Institut de Ge´nomique Fonctionnelle, INSERMU661, Centre National de la Recherche Scientifique (CNRS) UMR 5203,
Universite´s de Montpellier, 34094 Montpellier, France
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder affectingmotoneurons.Mutations in angiogenin, encod-
ing a member of the pancreatic RNase A superfamily, segregate with ALS. We previously demonstrated that angiogenin administration
shows promise as a neuroprotective therapeutic in studies using transgenic ALSmice and primarymotoneuron cultures. Itsmechanism
of action and target cells in the spinal cord, however, are largely unknown. Using mixed motoneuron cultures, motoneuron-like NSC34
cells, and primary astroglia cultures as model systems, we here demonstrate that angiogenin is a neuronally secreted factor that is
endocytosed by astroglia andmediates neuroprotection in paracrine.We show that wild-type angiogenin acts unidirectionally to induce
RNA cleavage in astroglia, while the ALS-associated K40I mutant is also secreted and endocytosed, but fails to induce RNA cleavage.
Angiogenin uptake into astroglia requires heparan sulfate proteoglycans, and engages clathrin-mediated endocytosis.We show that this
uptakemechanismexists formouse andhuman angiogenin, anddelivers a functional RNase output.Moreover, we identify syndecan 4 as
the angiogenin receptor mediating the selective uptake of angiogenin into astroglia. Our data provide new insights into the paracrine
activities of angiogenin in the nervous system, and further highlight the critical role of non-neuronal cells in the pathogenesis of ALS.
Introduction
Amyotrophic lateral sclerosis (ALS) is a late-onset and fatal neu-
rodegenerative disease. Approximately 10% of ALS cases are
dominantly inherited. Themost common genetic determinant of
ALS is disruption to the Cu/Zn superoxide dismutase 1 (SOD1)
locus, at which a series of substitution mutations have been cat-
alogued, that can recapitulate the major disease features in trans-
genic animals (Rosen et al., 1993; Gurney et al., 1994). A curious
feature determining the disease state in SOD1 transgenic mice is
the influence of intercellular signaling pathways on disease onset
and progression. This feature was highlighted initially by reports
thatdiseasepenetrance in transgenicmice required the expressionof
mutant SOD1 (mSOD1) in anumberof tissues, as opposed to either
motoneurons or astroglia alone (Gurney et al., 1994; Gong et al.,
2000; Pramatarova et al., 2001). By usingmSOD1 chimeric animals,
it was also found that a minority of wild-type (WT) astroglia are
sufficiently protective to delay the onset of ALS within an mSOD1
majority background, by protecting mSOD1-expressing motoneu-
rons from cell death (Clement et al., 2003). These investigations
therefore support a pathogenesis in which mutant SOD1 disrupts
autocrine/paracrine pathways, which under normal circumstances
can provide robust neuroprotection when activated in astroglia
alone. Moreover, mSOD1-expressing glia may contribute to mo-
toneurondeathby secreting factors selectively toxic tomotoneurons
(Raoul et al., 2002; Di Giorgio et al., 2007; Nagai et al., 2007; Ya-
manaka et al., 2008). It is therefore clear thatmechanismsmediating
motoneuron death can be subverted or exacerbated by astroglial
functions and define paracrine interactions as critical regulators of
the ALS disease state.
A candidate paracrine system recently linked with the devel-
opment of ALS is the angiogenin signaling network (Greenway et
al., 2006). Angiogenin is a secretedRNase of the pancreatic RNase
A superfamily, showing rRNA and tRNA substrate cleavage, and
defined by its potency to induce neovascularization (Fett et al.,
1985; Shapiro et al., 1986; St Clair et al., 1987). Despite retaining
only 105- to 106-fold the activity of RNase A, the weak RNase
activity of angiogenin is critical to its angiogenic activity (Shapiro
and Vallee, 1989; Shapiro et al., 1989; Leland et al., 2002). The
majority of mutations that segregate with ALS do not signifi-
cantly alter the secondary structure or stability of the protein, but
rather disrupt its RNase function or subcellular distribution
(Moroianu and Riordan, 1994; Leland et al., 2002; Greenway et
al., 2006; Crabtree et al., 2007).
We previously showed that angiogenin treatment extends the
lifespan of transgenic ALS mice and is neuroprotective in vitro
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when applied to mixed primary motoneuron cultures (Kieran et
al., 2008; Sebastia` et al., 2009). The mechanism of action of an-
giogenin in the spinal cord as well as its receptor and target cells,
however, remain largely undefined. Here, we demonstrate that
angiogenin is a neuronally secreted protein that is endocytosed by
astroglia andmediates neuroprotection in paracrine.We demon-
strate that angiogenin targets astrocytes to induce RNA cleavage
and define the uptakemechanisms and binding proteins involved
in this process.
Materials andMethods
All experiments were performed under license from the Department of
Health and Children (B100/3534), and following ethical approval by the
Research Ethics Committee of the Royal College of Surgeons in Ireland.
Primary motoneuron and astrocyte cultures. Primary motoneuron cul-
tures were established fromE13C57mouse embryos of either sex (Camu
and Henderson, 1992). Spinal cord ventral horns were dissected from
individual embryos, and the ventral horn tissue was cut into 1 mm
pieces and incubated for 10 min in 0.025% trypsin in Ham F10modified
medium ( Invitrogen). The cells were then gently dissociated in complete
medium containing 0.4% BSA and 0.1 mg/ml DNase I (Sigma). Cells
were seeded at 5 104 /ml and maintained at 37°C and 5% CO2. Where
stated, uridine/fluorodeoxyuridine (20 M) was added to motoneuron
cultures from day 3 in vitro (DIV) to DIV 6 to inhibit glial proliferation.
Primary astrocyte cultures were prepared from P2 C57 Black 6 mouse
pups of either sex. Cortices were dissected and the meninges removed
before incubation inMinimumEssentialMedium ( Invitrogen) contain-
ing 0.025% trypsin and 0.1mg/ml DNase I for 15min at 37°C. The tissue
was triturated three times in DMEM (4.5 g/L glucose; Lonza) containing
0.1 mg/ml DNase I to dissociate cells. Astrocytes were plated in full
DMEM containing 2 mM L-glutamine (Sigma), 100 U/ml penicillin/
streptomycin (Sigma), and 10% (v/v) heat-inactivated fetal bovine se-
rum (FBS; Sigma). All assays were performed on cell cultures after
passage one containing75% astrocytes.
Tissue culture. Motoneuronal NSC34 (Camu and Henderson, 1992)
and MZ-294 (Hetschko et al., 2008) human astrocytoma cells were cul-
tured in high-glucose (4.5 g/L)DMEMcontaining 10% (v/v) FBS and 1%
penicillin/streptomycin. Brefeldin A (BFA; Sigma) was used from 0.1 to
10 M as indicated and tunicamycin (Qbiogene) was used at 500 nM. All
experiments were repeated in triplicate.
Western blotting and trichloroacetic acid precipitation of conditioned
medium. Cells were collected in SDS lysis buffer (62.5 mM Tris-HCl, pH
6.8, 10% glycerin, 2% SDS) supplemented with protease inhibitor mix-
ture and phosphatase inhibitors (Sigma). Protein content of cell lysates
was determined using a bicinchoninic acid (BCA) protein determination
kit (Pierce) and equal amounts of protein were diluted in Laemmli buffer
and separated by electrophoresis on 6–15% polyacrylamide gels after
boiling for 5 min. Gels were transferred onto nitrocellulose membranes
and blocked for 1 h in 5% milk in TBS plus 0.5% Tween 20 (Sigma).
Membranes were then incubated with primary antibodies overnight at
4°C on a roller mixer: Goat anti-angiogenin (1:1000; Merck PC317L),
mouse anti--actin (1:2500; Sigma), mouse anti--tubulin (1:2000;
Sigma), rabbit anti-glial fibrillary acidic protein (GFAP; 1:1000; Sigma),
rabbit anti-lamin A (1:500;Santa Cruz Biotechnology), rabbit anti-rab 5
(1:1000; Abcam), rabbit anti-green fluorescent protein (GFP; 1:1000;
Abcam), and rabbit anti-syndecan 4 (1:1000; Abcam). After three washes
the membrane was incubated with horseradish peroxidase-conjugated
secondary antibody (1:5000; Jackson ImmunoResearch) for 1 h at room
temperature. Finally, membranes were washed four times and incubated
with enhanced chemiluminescence substrate (Millipore) for 1 min be-
fore image capture using an LAS 3000 Reader (Fujifilm).
Cell fractionation to separate nuclei and cytosolic components was
performed as described previously (Engel et al., 2010).
Conditioned medium collected for Western blotting was first centri-
fuged for 5min at 2000 rpm to remove any floating cells, adjusted to 10%
trichloroacetic acid and incubated on ice for 30min. Precipitated protein
was collected by centrifugation at 14,000 rpm for 30 min and resus-
pended in 20 l of SDS-loading buffer and neutralized with 2 l of Tris
base (2.5 M). Protein content was determined by BCA assay before dilu-
tion in 6 loading buffer (0.5 M Tris-HCl, pH 6.8, 30% glycerol, 10%
SDS, and 0.6 M dithiothreitol) and boiling for 5 min.
Transient transfection and production of ang-conditionedmedium.Plas-
mids expressing humanWT or K40I angiogenin from a cytomegalovirus
(CMV) promoter together with DsRed translated from an internal ribo-
some entry site (pIRES2-DsRed2ANGWTor K40I) have been described
previously (Sebastia` et al., 2009). Empty pIRES-GFP plasmid was used
for control transfections. Plasmids expressing turboGFP-tagged synde-
can 4 under the control of the CMV promoter and shRNA vector
expressing a syndecan 4-specific shRNA construct (sequence GGTTCT
GGAGATCTGGATGACACGGAGGA) or a scrambled sequence under
the control of the U6 promoter along with turboGFP under the CMV
promoter (pGFP-V-RS) were purchased fromOrigene. The plasmid en-
coding GFP-tagged rAP180 C terminus was a kind gift from Dr. McMa-
hon (Doherty and McMahon, 2009), and the GFP-tagged dominant-
negative dynamin 1 construct was a kind gift from Dr. Marin (Damke et
al., 1994).
NSC34 cells were seeded at a density of 150,000 cells per ml in 6-well
plates and left to recover and reach 60% confluence (24 h). For each
condition, 3 g of DNA was mixed with 6 l Lipofectamine 2000 (Invit-
rogen) for 20 min and incubated overnight. Following transfection,
NSC34 cells were washed and culture medium was replaced with either
full medium or Neurobasal medium (containing penicillin/streptomy-
cin, L-glutamine, and FBS as stated) for generating conditionedmedium.
Astrocytes were seeded at a density of 3 105 cells per well of a 24-well
plate on poly-L-ornithine-coated coverslips and transfected after 24 h.
Transfection was performed by mixing 1 g of DNA with 2 l of Lipo-
fectamine 2000 per well for 20 min. After 8 h of syndecan 4, rAP180 and
dnDyn overexpression, or 48 h for syndecan 4 gene silencing in antibiotic-
freemedium, themediumwas replaced with full medium until cell treat-
ment with recombinant human angiogenin.
Paracrine RNA cleavage assay—RNA extraction and PAGE analysis.
Conditioned medium containing secreted ANG or ANG variants was
collected fromNSC34 cells, centrifuged for 5min at 2000 rpm to remove
any floating cells, and applied to sister NSC34 cell cultures or MZ-294
cells. A neutralizing angiogenin antibody (Merck PC317L) was used to
inactivate endogenous angiogenin. Cells were incubated and condi-
tioned for 1–3 h prior and total RNA was harvested using Trizol (Invit-
rogen). NSC34 cells were collected in 200 l of Trizol using the plunger
from a 1ml syringe, whereas for primarymotoneuron cultures in 24-well
plates cells were collected in 50 l of Trizol per well. Trizol extracts were
homogenized by triturationwith a p200 pipette and centrifuged at 12,000
rpm for 10min at 4°C. The cleared homogenate was transferred to a fresh
tube, adjusted to 20% chloroform (Sigma), and shaken for 15 s. After a 3
min incubation at room temperature, the samples were centrifuged at
13,000 rpm for 15 min (4°C) after which the aqueous (upper) phase was
collected. DNA was removed by precipitation with isopropanol (adjust-
ing to 10%; Sigma) and centrifugation (13,000 rpm for 5 min). RNAwas
precipitated by adjusting to 50% isopropanol and centrifuged for 15min
at 13,000 rpm. RNA pellets were washed with 75% ethanol and resolubi-
lized in 11 l of DEPC-treated H2O for 10 min at 55°C. RNA concentra-
tions were quantified by measuring the absorption of 1 l of RNA
solution at   260 nm on a NanoDrop spectrophotometer. RNA was
mixed with 2 loading buffer (90% formamide, 11 mM EDTA, pH 8.0,
and 0.2% Orange G) and 3–5 g was separated by electrophoresis on
15% polyacrylamide TBE-UREA gels for 95 min at 200 V (Yamasaki et
al., 2009). RNA was stained with SYBR Gold (Invitrogen) and visualized
by transillumination within an LAS 3000 Reader (Fujifilm).
Immunocytochemistry. Immunocytochemistry was performed on
NSC34, astrocyte, andmotoneuron cultures seeded on poly-L-ornithine-
coated coverslips in 24-well plates. Cells were washed in ice-cold PBS and
fixed for 20 min in 4% paraformaldehyde (PFA; Sigma-Aldrich) in PBS
and sucrose at room temperature. After washing in PBS, the cells were
blocked with 5% milk in PBS/0.1% Triton X-100 for 1 h at room tem-
perature. Coverslips were incubated with primary antibodies overnight
at 4°C: mouse anti-SMI-32 (1:1000; Abcam), goat anti-angiogenin (1:
500; Merck PC317L), rabbit anti anti-GFAP (1:500; Sigma), rabbit anti-
clathrin heavy chain (1:1000; Abcam), or rabbit anti-syndecan 4 (1:100;
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Abcam). Coverslips were washed in PBS/Triton X-100 and PBS and in-
cubated with secondary antibodies from Jackson ImmunoResearch for
1 h at room temperature: rhodamine red-conjugated anti-mouse IgG,
1:500; FITC-conjugated anti-rabbit IgG; and anti-goat IgG, 1:500. Cov-
erslips were washed and mounted in Vectashield containing 4,6
diamidino-2-phenylindole (DAPI, Vector Laboratories) and visualized
on a TE 2000-S epifluorescent microscope (Nikon). Colocalization anal-
ysis of angiogenin-containing vesicles with other vesicular markers was
performed using an LSM 710 confocal microscope (Zeiss) with Zen 2009
software. Quantification of angiogenin uptake-positive cells was per-
formed in a blinded fashion using AlphaEaseFC software (Alpha Inno-
tech) by scoring those cells as positive that showed a bright, punctuate
angiogenin staining and that were also positively stained with the respec-
tivemarker (SMI-32 orGFAP). Cells with a lack of angiogenin staining or
with diffuse angiogenin staining were scored as angiogenin uptake-
negative cells. Cells were counted from at least six random fields of view
per coverslip at 60-fold magnification; each condition was tested on two
coverslips. Syndecan 4 gene silencing was quantified by immunofluores-
cence analysis and compared with cells transfected with the scrambled
shRNA. The average intensity of the cellular syndecan 4 immunoflu-
orescence after background subtraction was divided by the average
intensity of GFP fluorescence to compensate for differences in trans-
fection efficiency.
Angiogenin uptake and localization in vitro. Recombinant human an-
giogenin was purchased fromR&D Systems and used at 100–1000 ng/ml
as indicated. Fluorescence and confocal images were captured using
Nikon eclipse TE300 or Zeiss AxioImager Z1 microscopes and LSM 510,
LSM 710, or LSM 780 (Zeiss) confocal microscopes, respectively. Cy-
tochalasin D (CytoD) and phalloidin-TRIC were obtained from Sigma.
Angiogenin-conditioned medium was prepared from motoneuron cul-
tures treatedwith angiogenin for 6 h, followed by an 18 hwashout period.
Proximity ligation assay.Proximity ligation assay (PLA)was conducted
on astrocytes seeded in 8-well chamber slides (IBIDI). Astrocytes were
treated with angiogenin and fixed in 4% PFA. Staining with primary
antibodies was performed similarly to conventional immunocytochem-
istry (mouse anti-angiogenin, 1:250; Abcam). Instead of using fluores-
cently labeled secondary antibodies, a proximity ligation approach was
applied following manufacturer’s instructions (Olink Bioscience). In
brief, samples were incubatedwith secondary antibodies conjugatedwith
DNA probes (minus and plus DNA probes). Probes were hybridized and
ligated, followed by amplification of the DNA template in a rolling circle
amplification reaction. Detection solution was added to identify ampli-
fied DNA. All reaction steps were performed in a humidity chamber at
37°C. Signals were detected using both a TE 2000-S epifluorescence mi-
croscope (Nikon) and an LSM 710 confocal microscope (Zeiss). Spots
were quantified using the blob-finder software provided byOlink Biosci-
ences on random 60-fold magnification epifluorescent images (settings,
minimal nucleus size 100 pixels; cytoplasm size 100 pixels; blob size 3
3 pixels) and counts were tested for statistical significance between three
separate experiments using Student’s t test.
Manipulation of endocytosis. The salt concentration and osmolarity of
Neurobasal were adjusted with NaCl, CaCl2, and sucrose (all from
Sigma) to correlate with the amount measured for DMEM (3000– 6400
mg/L NaCl, 200–264 mg/L CaCl2, and 235–335 mosm). All endocytosis
inhibitors were purchased from Sigma and used at the indicated concen-
trations and preincubation times: monodansylcadaverine (MDC; 0.2
mM, 1 h), methyl--cyclodextrin (MCD; 0.24%, 1 h), dynasore (40 or
160 M, 30 min), heparinase I (2.5 U/ml, 2 h), heparin (10 g/ml, 2 h),
and CytoD (1 g/ml, 1 h). The uptake of 1 g/ml angiogenin was deter-
mined after 1 h treatment in Neurobasal medium containing
L-glutamine and penicillin/streptomycin following cell fixation and im-
munofluorescence detection of angiogenin. For quantification, cells were
counted from at least six random fields of view per coverslip at 60-fold
magnification; each condition was tested on two coverslips. Values ob-
tained from triplicate experiments were statistically tested using Stu-
dent’s t test.
Motoneuron survival in vitro. Primary motoneuron cultures at DIV 7
were treated with AMPA (50 M; Tocris Cookson) and cotreated with
human recombinant angiogenin protein (100 ng/ml dissolved in sterile
PBS; R&D systems), angiogenin- conditioned medium, or denatured
angiogenin-conditioned medium for 24 h. Viability of motoneuron cul-
tures was assessed by reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide (MTT; Sigma).Motoneuron cultureswere
prepared in 96-well plates and treated as described above. MTT was
dissolved in PBS (5mg/ml) and diluted 1:10 in culturemedium, added to
cells, and incubated for 4 h at 37°C. The media was then replaced with
isopropanol containing 0.04 M hydrochloric acid. Reduced MTT was
quantified by absorption at  570 nm using a plate reader (Tecan). All
experiments were repeated in triplicate and compared statistically using
Student’s t test. Direct assessment of motoneuron survival was deter-
mined by immunostaining for themotoneuron-specific marker, SMI-32
(Kieran et al., 2008). After treatment, cultures were incubated in trypan
blue (Sigma) for 5 min, washed in PBS, and fixed with 4% PFA. Cultures
were then immunostained with antibodies to SMI-32 as described pre-
viously.Motoneuron death was quantified by counting only the SMI-32-
positive cells, with typical morphology (triangular shape and single, well
defined axon), large bodies (20 m), and with intact axons and den-
drites. Three nonoverlapping images per coverslip were captured at 40-
fold magnification and counted using AlphaEaseFC software.
Real-time qPCR. Total RNA was extracted using the RNeasy Mini Kit
(Qiagen). First-strand cDNA synthesis was performed using 2g of total
RNA as a template and Moloney murine leukemia virus reverse tran-
scriptase (Invitrogen) primed with 50 pmol of random hexamers. Quan-
titative real-time PCR was performed using the LightCycler (Roche
Diagnostics) and the QuantiTech SYBR Green PCR kit (Qiagen) as per
manufacturers’ protocols. Specific primers were designed using Primer3
software (http://frodo.wi.mit.edu/primer3). Sense and antisense primers
used were as follows: 5-CACAGATGGCCTTGATGTTG-3, 5-CTCT
GGCTCAGCATGACTCC-3, for murine ang1 and 5-AGGTGTGATG
GTGGGAATGG-3, and 5-GGTTGGCCTTAGGGTTCAGG-3 for
murine -actin. The generation of specific PCR products was confirmed
bymelting curve analysis and gel electrophoresis. The data were analyzed
using the LightCycler software 4.0 with all samples normalized to
-actin.
Results
Astroglia, but not primary motoneurons,
endocytose angiogenin
Our previous reports established angiogenin as a neuroprotective
factor for primary motoneurons (Kieran et al., 2008; Sebastia` et
al., 2009). To begin elucidating the mechanism of neuroprotec-
tion conferred by angiogenin we first investigated the subcellular
localization and uptake of recombinant human angiogenin
(rhAng) in mixed primary motoneuron cultures derived from
the ventral horn. Consistent with our previous reports (Green-
way et al., 2006), we found that under control conditions mo-
toneurons, which stain for the neurofilament marker SMI-32,
showed immunoreactivity for endogenous angiogenin when
compared with non-neuronal cells (Fig. 1A). This result was
quantitatively confirmed by evaluating ang1 mRNA expression
in mixed murine motoneuron cultures versus primary astro-
cyte cultures by qRT-PCR (Fig. 1B), and is in accordance with
previous published work showing the absence of angiogenin
expression in non-neuronal cells during mouse embryonic
development and neural development (Subramanian and
Feng, 2007).
We next investigated rhAng uptake by immunocytochemistry
from different developmental stages, fromDIV 1 through to DIV
9, over a time course of 30 min to 24 h. However, across these
conditions, we could not detect any changes in the intensity or
distribution of angiogenin immunofluorescence in SMI-32-
positive neurons by immunocytochemistry (Fig. 1C, top, com-
pare 1 and 6 h uptake). In contrast, cells in the non-neuronal
plane of the same primary mixed motoneuron cultures showed
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robust and rapid vesicular uptake of angiogenin (Fig. 1C, bot-
tom). We also examined rhAng uptake in primary motoneuron
cultures treated with physiologically relevant stressors vulnerable
to angiogenin-mediated neuroprotection. However, under
AMPA-induced excitotoxic stress, we were again unable to detect
any change to angiogenin immunoreactivity in neurons treated
with rhAng (data not shown).
Using primary astroglial cultures, we found that angiogenin
uptake occurred in cells costaining with the astrocyte marker
GFAP (Fig. 1D). Angiogenin uptake in primary astroglial cul-
tures was measured from 30 min and continued for the duration
of the 24 h time course (Fig. 1C, compare glial planes at 1 and 6h).
Using confocal lasermicroscopywe found that once internalized,
angiogenin immunoreactivity appeared to remain initially se-
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Figure 1. Uptake of recombinant angiogenin appears to be restricted to astroglia.A, Fluorescent images of DIV 7 primarymixedmotoneuron cultures costained for SMI-32 or GFAP (red) and Ang
(green) imaged from the same field at twodifferent focal planes: neuronal (top) andglial (bottom).B, Quantitative real-timePCRanalysis showingmurineang1 transcription levels in primarymixed
motoneuron- and astrocyte-enriched cultures relative to -actin mRNA (*p 0.05; Student’s t test). Data are from n 3 cultures each. C, Immunocytochemistry of rhAng-treated (1g/ml)
primary mixed motoneuron cultures costained for SMI-32 (red) and Ang (green). Images show staining in two different focal planes: neuronal (left) and glial (right). D, Representative image of
rhAng-treated (1g/ml) primary astrocyte cultures costained for GFAP (green) and Ang (red). E,Western blot of rhAng-treated (1g/ml) primary astrocyte lysate fractionated into cytosolic (Astro
Cyt) andnuclear (AstroNuc) fractionsprobed for LaminA (nuclearmarker), Rab5 (cytosolic protein), andAng [Longexposureblot shown forAng (AngLongExp)].F,Westernblot showing thekinetics
of nuclear translocation of rhAng over a 24 h time course uptake in primary astrocytes. Scale bars, 10m. All experiments were performed in duplicate with similar results.
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questered within cytosolic vesicles and restricted from the nu-
cleus and later entered the nucleus (data not shown). Subcellular
fractionation experiments of samples obtained after 24 h of
uptake confirmed these observations and demonstrated that
rhANGwas taken up into the cytosol, and that a fraction of rhAng
was present in the nucleus (Fig. 1E). Nuclear uptake of rhAng in
astrocytes was observed as early as 1 h after treatment, and peaked
after 6 h of exposure to rhAng (Fig. 1F).
We also examined uptake using fluorescein-labeled rhAng (fl-
rhAng; Kieran et al., 2008). However, again we were unable to
detect uptake in motoneurons from 30 min through 24 h (Fig.
2A, left, shown at 1 h). Instead, we observed robust fl-rhAng
uptake in non-neuronal cells of the glial plane (Fig. 2A, middle),
which could also be correlated with GFAP costaining (Fig. 2A,
right). Figure 2B provides a quantitative analysis of fl-rhAng up-
take in GFAP-positive cells.
Endocytosis was dependent on an intact actin cytoskeleton
and occurred in an energy-dependent manner, as treatment with
the actin-destabilizing agentCytoD (1g/ml; Fig. 2C,middle), or
treatment with the mitochondrial toxin sodium azide (10 mM;
Fig. 2C, right) inhibited fl-rhAng uptake compared with control
cultures (Fig. 2C, left). Figure 2D provides a quantitative analysis
of fl-rhAng uptake (after 1 h) in GFAP-positive cells in the pres-
ence or absence of CytoD. Treatment with azide induced a com-
plete inhibition of fl-rhAng uptake. As a negative control, excess
fluorescein used at the same concentration required for rhAng
labeling was applied to primary motoneuron cultures, but was
not taken up by neurons or astroglia (data not shown). Collec-
tively, these data show that exogenous angiogenin is poorly inter-
nalized by primarymotoneurons over 24 h; in contrast astrocytes
are primed to efficiently endocytose angiogenin and may be piv-
otal in mediating the neuroprotective output of angiogenin.
Motoneurons secrete angiogenin under stress, which is taken
up by glia
Angiogenin is a secreted protein originally purified and se-
quenced from the conditioned medium of an adenocarcinoma
cell line (Fett et al., 1985). The fact that neurons are naturally rich
in angiogenin, but do not efficiently endocytose the protein,
whereas as astroglia are deficient in angiogenin and appear
primed to take up the protein, provoked our hypothesis that
neurons release angiogenin as a signal to astroglia. We therefore
investigated the trafficking of angiogenin between neurons and
astroglia to define a presumed endogenous signaling route.
We first investigated endogenous angiogenin signaling in pri-
marymotoneuron cultures and used serumwithdrawal as a stress
stimulus to identify whether astrocytes in close proximity to mo-
toneurons showed upregulated angiogenin endocytosis. Under
control conditions, SMI-32-positive motoneurons (Fig. 2E, top
left) were enriched for angiogenin compared with neighboring
astroglia (Fig. 2E, top right) (Greenway et al., 2006) shown in
different focal planes of the same field. Under serum withdrawal
(Fig. 2E, bottom left), we observed that motoneurons became
slightly shrunken in appearance but did not show condensed or
fragmented nuclei or signs of cell death; however, neighboring
astroglia showed an obvious increase in the size and abundance of
angiogenin-positive vesicles (Fig. 2E, bottom right) from 17
puncta per cell (9) in full medium to 58 puncta per cell (23)
under serum withdrawal (data from n  20 and 40 cells in two
separate experiments). To quantify angiogenin secretion from
motoneurons, we conditioned medium from primary motoneu-
ron cultures for analysis by Western blot, but could not obtain
sufficient quantities for biochemical analyses (data not shown).
Therefore we transitioned to motoneuronal NSC34 cells, a pri-
mary motoneuron and neuroblastoma fusion cell line (Cashman
et al., 1992), to further study angiogenin secretion.
NSC34 cells have been widely used as a model to study bio-
chemical properties of motoneurons (Turner et al., 2005). By
Western blotting, we observed that NSC34 cells express angioge-
nin under normal conditions and induce angiogenin protein un-
der serum withdrawal stress (Fig. 2G, left), similar to primary
motoneuron cultures (Fig. 2F).Moreover, medium conditioned
by NSC34 cells cultured under serum withdrawal contained de-
tectable levels of angiogenin protein, measured by Western blot-
ting (Fig. 2G, right). It was not possible to directly measure
angiogenin secretion in the presence and absence of serumdue to
the disruption caused by serum proteins during electrophoresis.
Thus, since angiogenin contains a signal peptide for secretion, we
usedBFA to disrupt endoplasmic reticulum (ER) toGolgi protein
transport and confirm angiogenin secretion as an active cellular
process (Fig. 2G, far right).We found that BFAused at 0.3Mwas
sufficient to inhibit angiogenin secretion, without causing cell
permeabilization over 22 h, indicated by the lack of -tubulin
protein in conditioned medium. Consistent with previous re-
ports, we found that NSC34 cells secreted actin, which was not
affected by BFA treatment (Lafon-Cazal et al., 2003);hence it
served as a second negative control. Collectively, these findings
show that endogenous angiogenin is upregulated by serumwith-
drawal inNSC34 cells and secreted by amechanism relying on ER
and Golgi function.
We next determined whether angiogenin derived from
NSC34 cultures could be taken up by astrocytes. Under serum
withdrawal, purified astroglia showed very little endogenous an-
giogenin staining by immunocytochemistry (Fig. 2G, left). How-
ever, when astroglia were treated with medium conditioned by
NSC34 cells cultured under serum withdrawal, they showed ro-
bust vesicular uptake of the protein, similar to that observed
within astroglia in close proximity to primary motoneurons in
serum-deprived cultures (Fig. 2G, right).
To confirm the secretion of angiogenin fromNSC34 cells and
establish a model to test the paracrine functions of WT and ALS-
associated angiogenin mutants, we characterized the expression
and secretion of overexpressed human angiogenin (ANG). ANG
WT and K40I RNase inactive constructs were transfected into
NSC34 cells and analyzed for intracellular and extracellular pro-
tein by Western blotting (Greenway et al., 2006; Sebastia` et al.,
2009). We found that, under serum withdrawal, both WT and
mutant angiogenin were expressed and secreted to the same ex-
tent intracellularly and accumulated to the same extent extracel-
lularly (Fig. 3A). By immunocytochemistry, we observed that
overexpressed angiogenin localized to two distinct subcellular
regions: a perinuclear reticulate structure and puncta in the pu-
tative growth cone of NSC34 cells resembling secretory granules
(Fig. 3B, left) (Burgoyne andMorgan, 2003; Ohsawa et al., 2003).
Treatment with BFA (3 h, 0.3 M) disrupted the formation of
angiogenin granules in the peripheral regions of the cell from 100
to 18.5% (Fig. 3B, right; Fig. 3C). As a negative control, overex-
pressed GFP did not localize to the ER or Golgi, but distributed
diffusely throughout the cytosol and nucleus (data not shown).
By loading the same proportion of protein from intracellular and
extracellular lysates, we quantified that angiogenin was secreted
at greater than twofold than the amount which was retained in-
tracellularly (Fig. 3D). Finally, we found that astrocytes treated
with conditioned medium from NSC34 cultures overexpressing
5028 • J. Neurosci., April 11, 2012 • 32(15):5024–5038 Skorupa et al. •Motoneurons Secrete Angiogenin to Induce RNA Cleavage
A SMI-32, FI-Ang, DAPI GFAP, FI-Ang, DAPISMI-32, FI-Ang, DAPI
C
NaN3CytoDControl
Actin, FI-Ang, DAPI
E
Control
- Serum
SMI-32, Ang, DAPI
Tubulin
ExtracellularIntracellular
Ctrl     -Ser    
Ang
17 kDa -Ser     BFA
75 kDa
35  kDa
Actin
F
H Serum withdrawal +NSC-34 cMed
GFAP, Ang, DAPI
Ang
B
D
CytoD
Ctrl
*
0
10
20
30
40
50
0
10
20
30
40
50
%
 G
FA
P
-+
ve
 fl
- A
ng
 u
pt
ak
e
1hr 6hr 24hr
%
 G
FA
P
-+
ve
 fl
- A
ng
 u
pt
ak
e
+Ser -Ser 
G
Ang
Actin
MN 
Ang
Figure 2. Uptake of rhAng by primary mixed motoneuron cultures is an actin- and energy-dependent process. A, Representative images of neuronal plane of fluorescein-conjugated
rhAng (fl-Ang)-treated primary motoneuron cultures stained for SMI-32 (red), compared with glial plane. B, Quantification of fl-Ang uptake by GFAP-positive astroglia in primary mixed
motoneuron cultures over a 24 h time course. C, Uptake of fl-Ang in primary mixed motoneuron cultures with or without CytoD pretreatment (1g/ml; 1 h preincubation; stained red
for actin) or pretreated with NaN3 (10 mM). D, Quantification of fl-Ang uptake by GFAP-positive astroglia in primary mixed motoneuron cultures with or without CytoD pretreatment (1
g/ml; *p 0.05; mean SD; data from 10 –20 cells in two independent experiments). E, Representative images of primary mixedmotoneuron cultures in full medium or under serum
withdrawal (SMI-32, red; Ang, green). F, Western blot detecting Ang in lysates of mixed motoneuron cultures in full medium (Ctrl) or under serum withdrawal (Ser; left). G, Western
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in duplicate with similar results. Scale bars, 10m.
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WT and K40I ANG showed angiogenin
uptake by Western blotting; however,
GFP uptake was not detected (Fig. 3E).
Densitometrical analysis of WT and K40I
angiogenin protein accumulation in astro-
cytes relative to WT and K40I angiogenin
levelswithin the respective conditionedme-
diumrevealed, in two separate experiments,
a 45 and 48% reduction in K40I angiogenin
accumulation in astroglia compared with
WT angiogenin.
Collectively, these data prove that
NSC34 cells express and secrete endoge-
nous and overexpressed angiogenin by a
classical secretory pathway, and that se-
cretedWT, and to a lesser extent K40I an-
giogenin, are efficiently endocytosed by
astroglia.
Angiogenin confers neuroprotection
in paracrine
Our group has previously demonstrated
that the exogenous addition of angiogenin protects primary mo-
toneuron excitotoxic effects of AMPA (Kieran et al., 2008). Since
angiogenin was preferentially endocytosed by astroglia, we
next tested whether the neuroprotection afforded by angioge-
nin was mediated in a paracrine way.
To this end, we generated conditionedmedium from primary
mixed motoneuron cultures treated with rhAng according to the
scheme outlined in Figure 4A. In brief, primary mixed cultures
were incubated with 100 ng/ml rhAng or heat-denatured rhAng
for 6 h, washed four times, and incubated for a further 18 h in
complete Neurobasal medium. The neuroprotective activity of
conditioned medium (cMed Ang or cMed denat Ang) was tested
against AMPA-induced excitotoxicity by applying it to sister
mixed motoneuron cultures for 30 min before AMPA (50 M)
treatment for 24 h. By MTT assay, we first observed that cMed
Ang significantly protected the viability of mixed motoneuron
cultures compared with AMPA and cMed denat Ang (Fig. 4B).
By SMI-32 immunocytochemistry we also observed that cMed
Ang increased the number of surviving motoneurons treated
with AMPA, statistically significant compared with cMed denat
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Figure 4. Angiogenin mediates neuroprotection through a paracrine pathway in primary mixed motoneuron cultures. A,
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Ang (Fig. 4C). These results confirm our previous observation
that angiogenin is a neuroprotective factor for motoneurons, but
demonstrate that the neuroprotective activity of angiogenin in
primary motoneuron cultures is mediated in paracrine.
Angiogenin mediates stress-induced
RNA cleavage in astrocytes
Previous work demonstrated that the neu-
roprotective activity of angiogenin is lost in
mutants that are deficient in itsRNase activ-
ity, suggesting that neuroprotection re-
quires RNA cleavage by angiogenin (Wu et
al., 2007; Kieran et al., 2008; Sebastia` et al.,
2009). Angiogenin is known to cleave tRNA
in a variety of mammalian cell lines (Fu et
al., 2009; Yamasaki et al., 2009). We were
therefore interested inexploring theeffectof
paracrine angiogenin signaling on RNA
cleavage in neurons and astrocytes.
We first assayed the RNase activity of
NSC34-conditionedmedium using astro-
glial cultures as a substrate. NSC34 cells
were cultured in full medium or under se-
rum withdrawal for 24 h, the conditioned
medium (NCM) was collected and ap-
plied to astroglia for 3 h, and RNA cleav-
age was assessed by electrophoresis (Fig.
5A) (Yamasaki et al., 2009). We found
that serum withdrawal NCM, but not full
medium NCM, induced intracellular
RNA fragmentation (Fig. 5A), indicating
that NSC34 cells upregulate and secrete a
factor which modifies the RNA profile of
astrocytes in paracrine under stress. In-
triguingly, the resulting RNA cleavage
products (40, 50, and 60 nt) were
not of a size consistent with that previ-
ously reported for tRNA cleavage (35
and45 nt; Yamasaki et al., 2009). These
data suggest that neural cells secrete fac-
tors under stress conditions that induce
RNA cleavage in astrocytes.
TodeterminewhetherNSC34-mediated
paracrine RNA cleavage could operate in an
autocrine manner, we tested the activity of
serum withdrawal NCM on sister NSC34
cultures (Fig. 5B, left). Under these condi-
tions, we could not detect any RNA cleav-
age, indicating that astrocytes are uniquely
sensitive to the NSC34-derived RNase in
this assay. We also conducted the experi-
ment in reverse to test whether astrocyte-
secreted factors could induce RNA cleavage
in NSC34 cells (Fig. 5B, right). Primary
mouse astrocyte cultureswere incubated for
24 h in either full medium or under serum
withdrawal afterwhich the conditionedme-
dium (ACM) was applied to NSC34 cells.
Again, however, we could not observe RNA
cleavage in NSC34 cultures. These results
suggested that RNA processing under stress
does not operate from neuron to neuron or
from astrocyte to neuron, but in a unidirec-
tional manner from neurons to astrocytes.
We next tested the ability of overexpressed human ANG to
induce RNA cleavage in astroglial cultures in paracrine. We first
characterized the RNase activity of overexpressed ANG on intra-
cellular RNA and found that WT ANG, but not K40I RNase in-
Figure 5. RNA processing in paracrine is stress inducible and restricted to a protein secreted by neurons acting specifically on
astroglia. A, RNA gels showing cleavage of astrocyte RNA collected under serum withdrawal (Ser, left) or in full medium (FM;
right) after treatmentwithNSC34-conditionedmedium (NCM; for 3 h).B, NSC34RNA collected under serumwithdrawal treated (3
h) with NSC34 (left)- or astrocyte (right)-conditioned medium (NCM/ACM; 24 h). C, Intracellular RNA cleavage in NSC34 cells
overexpressing wt hAng, Ang K40I, or GFP. D, Human MZ-294 astrocytoma RNA collected under serum withdrawal treated (3 h)
with conditioned medium (cMed) collected from NSC-34 cells overexpressing wt hAng, Ang K40I, or GFP (24 h). E, Comparison of
endogenous (NSC-34) and paracrine (MZ-294) RNA cleavage fragments and demonstration of lack of dominant-negative effect of
Ang K40I on Ang-induced RNA cleavage. NSC-34 cells were expressed with equal amounts of wt hAng, Ang K40I, or GFP as
indicated. Experiments were performed as described in C and D. E, Represents the same gel overexposed to highlight the
endogenous cleavage products in NSC34 cells. F, NSC34 RNA collected under serum withdrawal treated (3 h) with conditioned
medium collected from primary astrocytes overexpressing wt hAng, Ang K40I, or GFP (24 h). All experiments were performed in
duplicate with similar results. G, RNA cleavage in primary mixed motoneuron cultures under normal culture conditions (Ctrl) or
treated with heparin (1g/ml; 1 or 8 h; left; performed in triplicate with similar results) and treated with heparin (Hep) or an
Ang-inactivating antibody (Ang; 2g/ml; 24 h; right).
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active ANG, induced RNA cleavage—consistent in size with
previously reported tRNA halves (Yamasaki et al., 2009)—when
overexpressed in NSC34 cells (Fig. 5C). We next tested the po-
tency of secreted overexpressed human angiogenin to induce
RNA cleavage in astroglia in paracrine (Fig. 5D). To avoid any
potential species barriers, we applied NCM from humanWT and
K40I ANG overexpressing NSC34 cells to MZ-294 cells, a GFAP-
positive human astrocytoma culture (Hetschko et al., 2008). We
observed thatWT, but not K40IANGNCM, induced RNA cleav-
age in human astrocytes. Again, however, the cleavage fragments
in human astrocytoma cells were not of a size consistent with
tRNA cleavage, but consistent with size of fragments observed in
serum withdrawal NCM-treated mouse astroglia (Fig. 5A).
To study the potential dominant-negative effect of ALS-
associate angiogenin mutant K40I, we cotransfected NSC34 cells
with bothWT and K40IANG (Fig. 5E). Cotransfection with GFP
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was used as control. No inhibitory effect of K40I ANG over WT
was observedboth in the endogenous and the paracrineRNAcleavage.
Figure5EshowsalongerexposureofthesamegelshowninFigure5Eto
highlight the difference in endogenous versus paracrineRNAcleavage.
We further investigated thedirectionalityof angiogenin signaling
between neurons and astroglia by conducting the experiment in
reverse. Conditioned medium from astroglia overexpressing human
WTandK40IANGwasappliedtoNSC34cells.Wecouldnotdetectany
RNA cleavage inNSC34 cells induced by overexpressed human angio-
genin in paracrine (Fig. 5F).
We next sought to determine whether intercellular motoneu-
ron to astroglial angiogenin signaling was a natural feature of
mixed primary motoneuron cultures, using RNA cleavage as a
readout. We harvested total RNA from mixed cultures under
control conditions and observed constitu-
tive RNA fragmentation at40,50, and
60 nt, consistent with the paracrine
RNA fragmentation pattern observed in
mouse and human astrocytes (Fig.
5A,D,G). We then tested whether this ac-
tivity is mediated by secreted factors or by
angiogenin in particular. Angiogenin has
been characterized as a heparin-binding
protein and is likely to require heparan
sulfate proteoglycans to mediate uptake
into astrocytes, a mechanism known to be
involved in the uptake of other angiogenic
molecules such as basic fibroblast growth
factor/fibroblast growth factor-2 (bFGF/
FGF-2) and vascular endothelial growth
factor (VEGF; Soncin et al., 1997; Kirkpat-
rick and Selleck, 2007). To determine
whether constitutive RNA cleavage of
mixed primary motoneuron cultures was
caused by a paracrine factor consistent with
this mechanism, we applied heparin (1 g/
ml) to the culture medium and observed a
strong inhibition of RNA cleavage (Fig. 5G,
left). This experiment proved that constitu-
tive RNA cleavage occurred in paracrine,
but also revealed the rapidity by which the
RNA cleavage products are turned over
(within 1 h of heparin treatment), and no
RNA cleavage products were detectable. To
prove that paracrineRNAcleavage inmixed
motoneuron cultures was mediated by an-
giogenin, we used an angiogenin-
inactivating antibody (2 g/ml; see
Materials andMethods),whichwe added to
the culture medium. After a 24 h antibody
treatment, the amount of RNA cleavage in
primary motoneuron cultures was promi-
nently reduced (Fig. 5G, right), demonstrat-
ing thatmotoneurons secrete angiogenin to
induce RNA cleavage in astrocytes.
Astroglia take up angiogenin via
clathrin-mediated endocytosis
To explain the astroglial-specific responses
to secreted or exogenously applied angioge-
nin, we next decided to characterize the
mechanism of angiogenin uptake into as-
troglia.We first confirmed that the addition
of extracellular heparin to the cell culture medium or heparinase I
preincubation inhibited the endocytosis of exogenously applied an-
giogenin in primary astroglial cultures. Heparinase I is a bacterial
enzyme which removes heparan sulfates from the cell surface,
thereby impeding heparan sulfate proteoglycan-aided endocytic
events (Roghani and Moscatelli, 1992). By immunocytochemistry
andWestern blotting we observed that heparin (1g/ml) abolished
the uptake of angiogenin, while the effect of heparinase I was less
pronounced (Fig. 6A–C). We also confirmed this result in human
astrocytoma cells using NCM from NSC34 cells expressing WT
ANG, in which the addition of extracellular heparin potently inhib-
ited the uptake of secreted angiogenin (Fig. 6D).Heparin inhibition
of angiogenin uptake also correlated with a robust inhibition of
paracrine RNA cleavage (Fig. 6E).
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The interaction of extracellular ligands
with cell-surface heparan sulfate pro-
teoglycans is disturbed under increasing
concentrations of NaCl (Eckert and Ragg,
2003). Other reports suggested a strong
dependence of endocytic events on both
the osmolarity of the medium and both
the sodium and calcium concentration
(Daukas and Zigmond, 1985; Heuser and
Anderson, 1989; Jiang and Chen, 2009).
We used these features to further delin-
eate the mechanism of angiogenin uptake
in astrocyte cultures by increasing the so-
dium and calcium concentration and os-
molarity of Neurobasal medium. Sodium
and calcium concentrations and osmolar-
ity were separately adjusted to those pres-
ent in DMEMculturemedium, amedium
commonly used in tissue culture of neural
and non-neural cells (3000–6400 mg/L
NaCl, 200–264 mg/L CaCl2, and 235–335
mosm) (Brewer et al., 1993). Interest-
ingly, only increases in the concentration
of NaCl resulted in the inhibition of an-
giogenin uptake, quantified by immuno-
cytochemistry and Western blotting (Fig.
6F–H).
From the punctate angiogenin staining
pattern observed in our experiments, we
set out to further investigate the mecha-
nism of angiogenin uptake in astrocytes.
To distinguish the twomain endocytic routes, clathrin-mediated
endocytosis (CME) or lipid raft-mediated endocytosis, we used
MDC, a known inhibitor of CME (Gutie´rrez-Ortega et al., 2008),
or the cholesterol extraction agent MCD, an inhibitor of lipid
raft-mediated endocytosis (Vercauteren et al., 2010). MDC re-
duced the number of angiogenin vesicle-containing astroglia
from 60 to 15% (Fig. 7A), whereas MCD showed no effect.
Furthermore, we found that angiogenin-positive vesicles colocal-
ized with clathrin as analyzed by confocal immunofluorescence
microscopy (Fig. 7B, top; control experiments without angioge-
nin addition). Finally, expression of rAP180-GFP, a truncated
and dominant-negative form of the AP180 clathrin adaptor
(Doherty and McMahon, 2009), potently inhibited angiogenin
uptake into astrocytes (Fig. 7C, left).
To confirm a general clathrin-dependent mechanism for an-
giogeninuptakewe finally investigated the requirement for the small
GTPase dynamin, which is essential for clathrin-dependent vesicle
formation (Doherty andMcMahon, 2009). We treated primary as-
trocyte cultures with dynasore, a small molecule inhibitor of dy-
namin which interferes with its GTPase activity (Macia et al., 2006;
Tu et al., 2010), or transfected cells with a dominant-negative dy-
namin construct (Damke et al., 1994), before the addition of
angiogenin. Both dominant-negative dynamin (Fig. 7C, middle)
and dynasore (Fig. 8A,B) inhibited angiogenin uptake in mouse
astroglia cultures, thereby showing a dependency on dynamin for
the uptake mechanism.
Finally, we confirmed that this uptake mechanism is vital to
angiogenin endocytosis and paracrine RNase cleavage and operated
also in human cells. NCM from NSC34 cells expressing WT ANG
was added in the absence or presence of elevated sodiumchloride or
dynasore. Both NaCl and dynasore robustly inhibited human
angiogenin-mediated, paracrine RNA cleavage in human astro-
cytoma cells (Fig. 8C). Collectively, these data show that angiogenin
endocytosis is a clathrin-dependent, heparan sulfate proteoglycan-
assisted mechanism and that disruption to either of these compo-
nents inhibits angiogenin endocytosis and concomitant paracrine
RNA cleavage.
The receptor for angiogenin uptake into astrocytes is
syndecan 4
To delineate the specificity of angiogenin uptake into astroglia,
we decided to identify its receptor on astroglia. Cell surface hepa-
ran sulfate proteoglycans are contained within either the synde-
cans, which contain a single transmembrane domain, or the
glypicans, which are tethered to the plasma membrane with a
glycosylphosphatidylinositol anchor (Kirkpatrick and Selleck,
2007). Although these receptors lack catalytic activity, syndecan 4
is unique in being capable of binding phosphatidylinositol (4,5)-
P2, therefore independently initiating signaling via Rac1, protein
kinase C, PI3K, Cdc42, mTORC2, and Akt (Ilan et al., 1998;
Simons andHorowitz, 2001; Tkachenko et al., 2004; Partovian et
al., 2008). Previous reports have also demonstrated that the up-
take of angiogenicmolecules such as bFGF, which requires astro-
glia tomediate neuroprotection in vitro, ismediated via syndecan
4, the in vivo expression of which appears to be restricted to glial
lineages (Knusel et al., 1990; Engele and Bohn, 1991; Hou et al.,
1997; Hsueh and Sheng, 1999; Tkachenko et al., 2004).We there-
fore investigated whether angiogenin endocytosis was mediated
by syndecan 4.
By confocal microscopy, we observed that astrocytes express
syndecan 4 under control conditions, which upon rhAng treat-
ment, redistributed to colocalize with angiogenin-positive vesi-
cles (Fig. 9A). To confirm this observation in a second approach,
we used the in situ PLA (So¨derberg et al., 2006). This assay detects
B C
A
GFAP
Ang
DAPI
Ang Dynasore 40 µM Dynasore 160 µM
Ang
Ctrl DynS NaCl Ctrl DynS NaCl
pAng NcMed Vector NcMed
43 nt
34 nt
*
*
0
10
20
30
40
50
60
70
80
90
100
Neurobasal   40µM
Dynasore
160µM
Dynasore
%
A
ng
po
s.
as
tr
oc
yt
es
Figure 8. Inhibition of angiogenin uptake with dynasore reduces paracrine RNA cleavage. A, Immunocytochemistry of rhAng-
treated (1g/ml; 1 h; red) primary astrocytes with or without pretreatment with dynasore (40 and 160M; 30 min preincuba-
tion), quantification (B, *p0.05;mean SD;n3).C, RNAgel of humanastrocytoma treatedwithNSC34-derivedhAng in the
presence or absence of NaCl (3.4mg/L) or dynasore (DynS; 40M; performed in duplicatewith similar results). Scale bars, 25m.
5034 • J. Neurosci., April 11, 2012 • 32(15):5024–5038 Skorupa et al. •Motoneurons Secrete Angiogenin to Induce RNA Cleavage
interactions of proteins in fixed cells, and gives more information
about the exact localization of the interaction partners. Figure 9B
illustrates that fixed, angiogenin-treated astrocytes showed many
points of interaction between syndecan 4 and angiogenin (reported
as red spots). There was little background by unspecific antibody
interaction as shown by using an antibody against GFAP in combi-
nationwith the angiogeninantibody (Fig. 9B).Quantificationof this
interaction using blob-finder software (seeMaterials andMethods)
showed that significantly more spots were detectable in the
angiogenin-treated versus vehicle-treated astrocytes (Fig. 9C).
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To prove that syndecan 4 was essential for rhAng uptake in
astroglial cells, we used shRNA technology to silence syndecan 4
expression. Due to limited transfection efficiency in primary as-
troglia, it was not possible to quantify the inhibition of syndecan
4 expression by Western blotting. Instead, confocal microscopy
was used to analyze syndecan 4 immunofluorescence in cells co-
expressing GFP (Fig. 9D). Figure 9E provides a quantitative anal-
ysis of the most efficient shRNA vector tested that targeted
syndecan 4. Analysis of GFP-expressing cells showed that trans-
fectionwith this shRNA reduced angiogenin uptake by 48%com-
pared with scrambled shRNA transfected controls (Fig. 9F,G).
Finally, we tested whether expression of syndecan 4 was suffi-
cient tomediate rhAng uptake intoNSC34 cells. Figure 9H shows
that NSC34 cells expressing GFP-syndecan 4 showed a vesicular
uptake of angiogenin, similar to that observed in rhAng-treated
astrocytes, whereas untransfected cells showed little detectable
angiogenin uptake. As an additional negative control, GFP ex-
pression did not mediate angiogenin uptake in NSC34 cells (data
not shown). Thus, syndecan 4 appeared to be necessary and suf-
ficient to mediate angiogenin endocytosis.
Discussion
Through our investigations, we have elucidated a comprehensive
mechanism of angiogenin signaling within cells of the spinal
cord. We have highlighted a novel endogenous angiogenin sig-
naling pathway betweenmotoneurons and astroglia. Our studies
indicate that angiogenin is a neuronally derived protein which
constitutively and induciblymodifies the RNAprofile of astroglia
in paracrine. Importantly, we provide substantial evidence that
the endogenous receptor for angiogenin in cells of spinal cord
origin is syndecan 4, expressed exclusively by astroglia.
Motoneurons are polytrophic and show protection mediated
by a variety of angiogenic growth factors, such as VEGF and FGF,
via the expression of high-affinity receptors such as flk1, flt1, and
FGFR1 (Gonzalez et al., 1995; Sendtner et al., 2000; Lambrechts
and Carmeliet, 2006; Poesen et al., 2008). Most neurons require
signaling endosomes to ensure sufficient prosurvival signaling
reaches the nucleus (Howe and Mobley, 2005). In support of
previously published data (Greenway et al., 2006), we found that
motoneurons endogenously express angiogenin. However, we
could find no evidence of uptake or endocytosis of exogenously
applied angiogenin by motoneurons through immunocyto-
chemistry or using fluorescently labeled rhAng. We also used a
functional RNase readout in NSC34 cells; however, we failed to
detect any RNA cleavage in response to exogenous angiogenin,
despite robust activity in astroglia.
We found that motoneuronal NSC34 cells secrete both en-
dogenous angiogenin and overexpressed angiogenin in a BFA-
sensitive manner (Rosa et al., 1992). By immunocytochemistry
we showed that angiogenin overexpressed in NSC34 cells local-
izes to a tunicamycin-sensitive perinuclear reticulate structure
and Golgi function-dependent granular structures before secre-
tion. This ER–Golgi trafficking is consistent with the angiogenin
protein sequence, which contains a hydrophobic amino acid-rich
signal peptide, strongly predicted to couple translation with ER
translocation and secretion (Kurachi et al., 1985; Barash et al.,
2002). Our data support previous studies showing similar peri-
nuclear/ER localization of endogenous angiogenin and also sug-
gest a regulated release of angiogenin protein by secretory granule
exocytosis (Kurachi et al., 1985; Pavlov et al., 2003). This mech-
anism of secretory granule packaging and regulated release is
known for other angiogenic factors such as VEGF and FGF-2,
which regulate stimulus-dependent angiogenesis by platelets
(Ribatti et al., 2001; Italiano et al., 2008). Thus, we believe that
neurons constitutively express angiogenin and traffic the protein
into secretory granules for both constitutive and stress-induced
secretion.
We found RNA processing to present a robust readout for
angiogenin activity in paracrine. We proved that angiogenin se-
creted fromNSC34 cells mediates RNA cleavage in cells of astro-
cyte origin in paracrine (Fig. 5A,D,G). Interestingly, the RNA
fragments in astrocytes migrated at a different size to that ob-
served when expressed within NSC34 cells and to what is ex-
pected for the reported tRNA cleavage products (Fig. 5C,E)
(Yamasaki et al., 2009). The paracrine RNA fragments showed a
consistent size in all three models tested: endogenous NSC34 to
mouse astroglia, overexpressed NSC34 angiogenin to human as-
trocytoma, and endogenously within mixed primary motoneu-
ron cultures. Our data do not exclude a biological function of
intraneuronal tRNA cleavage by angiogenin. Angiogenin has also
been shown to have direct neurotrophic activities in the develop-
ment of motoneurons, including axon pathfinding (Subrama-
nian and Feng, 2007;Wu et al., 2007).However, our results rather
suggest that angiogenin exerts important additional biological
functions by acting in paracrine, and that angiogenin regulates
astroglia function by targeting novel subsets of RNAs. Future
studies will need to identify and characterize these novel angio-
genin RNA substrates.
To gain further insight into the mechanism of angiogenin
neuroprotection and its endogenous role in the spinal cord, we
also delineated the mechanism of angiogenin uptake in astroglia.
Similar to the endocytosis pathway for a variety of extracellular
ligands, we found angiogenin uptake to be consistent with hepa-
ran sulfate proteoglycan-assistedCME (Belting, 2003;Dreyfuss et
al., 2009). It has been shown previously that angiogenin binds
heparin and cell surface proteoglycans (Soncin et al., 1994, 1997).
However, we have shown that excess heparin can compete with
the angiogenin receptor on astrocytes and prevent its uptake and
concomitant paracrine RNA cleavage. We also showed that the
endocytic mechanism for astroglial angiogenin uptake is CME,
requiring dynamin-mediated vesicle budding, again by both im-
munocytochemistry and using RNase activity as a functional
readout. Moreover, we have now defined syndecan 4 as a bona
fide receptor for angiogenin, based on a variety of experimental
approaches.With angiogenin uptake colocalizedwith syndecan 4
in cytosolic astroglial endosomes, and using the in situ proximity
ligation assay, we could prove that the two proteins are posi-
tioned within close proximity (40 nm) of each other. We fur-
ther showed that syndecan 4 gene silencing inhibits angiogenin
uptake in astrocyte cultures, thereby proving it to be necessary for
astroglial angiogenin endocytosis. Finally, we showed that synde-
can 4 overexpression is sufficient to reconstitute angiogenin en-
docytosis in cells that do not show significant basal angiogenin
uptake or express detectable levels of endogenous syndecan 4.
Thus, we conclude that angiogenin interacts specifically with as-
troglial syndecan 4, which is both necessary and sufficient for its
uptake. This finding suggests an explanation for the cell type-
specific uptake of angiogenin inmixed primarymotoneuron cul-
tures, since the in vivo expression of syndecan 4 is restricted to
astroglia (Hsueh and Sheng, 1999).
Astrogliamay, however, not be the sole cell type responding to
motoneuron-derived angiogenin. Syndecan 4 is also expressed by
endothelial cells wherein it regulates multiple aspects of angio-
genesis including ligand endocytosis (e.g., FGF-2 and VEGF) and
stimulates endothelial migration and tubularization (Tkachenko
et al., 2004, 2006; Nunes et al., 2008). This raises the possibility
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that motoneuron-derived angiogenin may stimulate endothelial
cells to induce neovascularization. Moreover, astrocytes directly
contact 99% of the endothelial basement membrane, where
they regulate microvasculature blood flow (Iadecola and Neder-
gaard, 2007). Astroglia may use angiogenin to transmit intercel-
lular signals to endothelial cells or may mediate angiogenin
transcytosis to the endothelial membrane.
Together, our results provide new biological insights into the
regulation of RNAmetabolism in neurons and astrocytes and the
role of angiogenin in this process.Moreover, our results also raise
the prospect that angiogenin therapy may prove efficacious in
human ALS patients.
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